These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 16635297)
21. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells. Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530 [TBL] [Abstract][Full Text] [Related]
22. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis. Li J; Shen F; Wu D; Wei LX; Wang YZ; Shi LH; Zou Y; Wu MC Oncol Rep; 2007 May; 17(5):1067-75. PubMed ID: 17390046 [TBL] [Abstract][Full Text] [Related]
23. Modulation of gene expression in MHCC97 cells by interferon alpha. Wu WZ; Sun HC; Wang L; Chen J; Liu KD; Tang ZY World J Gastroenterol; 2005 Nov; 11(42):6613-9. PubMed ID: 16425353 [TBL] [Abstract][Full Text] [Related]
25. JAK/STAT pathway mediates retinal ganglion cell survival after acute ocular hypertension but not under normal conditions. Huang Y; Cen LP; Choy KW; van Rooijen N; Wang N; Pang CP; Cui Q Exp Eye Res; 2007 Nov; 85(5):684-95. PubMed ID: 17869246 [TBL] [Abstract][Full Text] [Related]
26. Rapid inhibition of MAPK signaling and anti-proliferation effect via JAK/STAT signaling by interferon-alpha in hepatocellular carcinoma cell lines. Inamura K; Matsuzaki Y; Uematsu N; Honda A; Tanaka N; Uchida K Biochim Biophys Acta; 2005 Sep; 1745(3):401-10. PubMed ID: 16054712 [TBL] [Abstract][Full Text] [Related]
27. Mining for JAK-STAT mutations in cancer. Constantinescu SN; Girardot M; Pecquet C Trends Biochem Sci; 2008 Mar; 33(3):122-31. PubMed ID: 18291658 [TBL] [Abstract][Full Text] [Related]
28. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro. Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692 [TBL] [Abstract][Full Text] [Related]
29. [Interferon alpha enhances the sensitivity of SMMC-7721 hepatocellular carcinoma cells to 5'-deoxy-5-fluorouridine related to up-regulation of thymidine phosphorylase]. Xiao YS; Zhou J; Fan J; Zhao Y; Sun RX; Liu YK; Ye SL; Tang ZY Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2098-100. PubMed ID: 17988526 [TBL] [Abstract][Full Text] [Related]
30. Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2. Marijanovic Z; Ragimbeau J; van der Heyden J; Uzé G; Pellegrini S Biochem J; 2007 Oct; 407(1):141-51. PubMed ID: 17627610 [TBL] [Abstract][Full Text] [Related]
31. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines. Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941 [TBL] [Abstract][Full Text] [Related]
32. Melanoma cells exhibit variable signal transducer and activator of transcription 1 phosphorylation and a reduced response to IFN-alpha compared with immune effector cells. Lesinski GB; Trefry J; Brasdovich M; Kondadasula SV; Sackey K; Zimmerer JM; Chaudhury AR; Yu L; Zhang X; Crespin TR; Walker MJ; Carson WE Clin Cancer Res; 2007 Sep; 13(17):5010-9. PubMed ID: 17785551 [TBL] [Abstract][Full Text] [Related]
33. Complex modulation of cell type-specific signaling in response to type I interferons. van Boxel-Dezaire AH; Rani MR; Stark GR Immunity; 2006 Sep; 25(3):361-72. PubMed ID: 16979568 [TBL] [Abstract][Full Text] [Related]
35. [The role of FAK expression inhibition by RNA interference on liver cancer cells]. Yuan Z; Zheng Q; Huang XY; Fan J Zhonghua Wai Ke Za Zhi; 2007 Oct; 45(19):1350-3. PubMed ID: 18241574 [TBL] [Abstract][Full Text] [Related]
36. [The role of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance of hepatocellular carcinoma]. Zhu H; Chen XP; Luo SF; Guan J; Zhang WG; Zhang BX; Mao CP Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(13):917-20. PubMed ID: 17953842 [TBL] [Abstract][Full Text] [Related]
37. The signal transduction mediated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy. Tao W; Wen F; Zhang H; Liu G Brain Dev; 2009 Mar; 31(3):200-7. PubMed ID: 18715729 [TBL] [Abstract][Full Text] [Related]
38. The interferon-stimulated gene factor 3 complex mediates the inhibitory effect of interferon-beta on matrix metalloproteinase-9 expression. Zhao X; Nozell S; Ma Z; Benveniste EN FEBS J; 2007 Dec; 274(24):6456-68. PubMed ID: 18028425 [TBL] [Abstract][Full Text] [Related]
39. Acetylation-dependent signal transduction for type I interferon receptor. Tang X; Gao JS; Guan YJ; McLane KE; Yuan ZL; Ramratnam B; Chin YE Cell; 2007 Oct; 131(1):93-105. PubMed ID: 17923090 [TBL] [Abstract][Full Text] [Related]
40. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT. Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]